NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Latigo Biotherapeutics, Inc. Common Stock Share Price Chart

O H L

Latigo Biotherapeutics, Inc. Common Stock Performance Overview

Days Range
$23.50Low
$24.25High

Markets Today

Previous Close$23.93
Open$24.25
Volume33,985
Day's Range$23.50 - $24.25
52W RangeNA
Market Cap$1.53 B

Historical Performance

1M Returns+19.65
3M ReturnsNA
6M ReturnsNA
1Y ReturnsNA
5Y ReturnsNA
10Y ReturnsNA

Latigo Biotherapeutics, Inc. Common Stock Fundamentals

Market Cap$1.53 B
Dividend yieldN/A
PE RatioN/A
PEG RatioN/A
RevenueN/A
ROE TTMN/A
EPS TTMN/A
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDAN/A
Profit MarginN/A
Market Cap$1.53 B
Dividend yieldN/A
PE RatioN/A
PEG RatioN/A
RevenueN/A
ROE TTMN/A
EPS TTMN/A
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDAN/A
Profit MarginN/A

Latigo Biotherapeutics, Inc. Common Stock Return Calculator

The Latigo Biotherapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
Invest in USA Stock Today

About Latigo Biotherapeutics, Inc. Common Stock

Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.

FAQs

Latigo Biotherapeutics, Inc. Common Stock (LTGO) share price as of September 18, 2026 is $23.05. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Latigo Biotherapeutics, Inc. Common Stock (LTGO) Share by opening an international trading account with Angel One.
Purchasing Latigo Biotherapeutics, Inc. Common Stock (LTGO) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Latigo Biotherapeutics, Inc. Common Stock (LTGO) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Latigo Biotherapeutics, Inc. Common Stock (LTGO) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Latigo Biotherapeutics, Inc. Common Stock on September 18, 2026, is $1.53 B.
Latigo Biotherapeutics, Inc. Common Stock operates in the null sector, specifically in the null industry.
In order to invest in Latigo Biotherapeutics, Inc. Common Stock (LTGO) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91